Public Health Buyers Would Favor Local PPE

Summary#

S-10738, the “NYS PPE resilience & manufacturing act,” would amend New York’s State Finance Law by adding a purchasing rule for personal protective equipment (PPE). Its stated goal is to support New York PPE manufacturing and resilience; the bill does not guarantee those results. It is at the introduced stage and has been referred to Rules, so it is not law.

  • State-funded health care entities would have to buy New York-made PPE under contracts over $50,000, if that equipment is available and meets required specifications for form, function and utility.
  • Covered entities include state agencies (including SUNY and CUNY), state-funded hospitals and nursing homes, and certain community health, diagnostic and treatment, and federally qualified health centers receiving state aid or grants.
  • A commissioner could waive the rule if the PPE is not produced in New York in any quantity, or if New York-made comparable PPE costs more than 20% above out-of-state PPE.
  • Each waiver would have to be posted on the Office of General Services website for at least 15 days for public comment before the contract is finalized.

What it means for you#

  • Covered health care entities: For qualifying PPE contracts over $50,000, they would have to buy New York-made products that meet the stated availability and specification conditions, unless a waiver is granted.
  • New York PPE manufacturers: They could gain access to purchases covered by the rule, but the bill does not guarantee any sales or contracts.
  • Patients and the general public: The bill does not directly change health care services, patient eligibility, or PPE access rules.
  • Taxpayers: The bill does not create a tax or fee. The cost of purchasing PPE could change depending on product prices and available waivers.

Money#

No cost estimate is provided in the available material.

  • The bill requires covered entities to buy New York-made PPE for qualifying contracts, but gives no estimate of any higher purchase costs.
  • It does not appropriate money or set aside funding for implementation.
  • The bill does not specify staffing, enforcement costs, or savings.

What is unclear#

  • The text does not clearly say whether the $50,000 threshold applies only to contracts for PPE, or how it applies if a larger contract includes PPE among other goods or services.
  • The bill uses the PPE definition in another State Finance Law section, but that section is not supplied, so the scope of the definition cannot be verified here.
  • It refers to “the commissioner” without identifying which commissioner.
  • It does not set out how entities would document compliance, how waivers would be decided beyond the stated grounds, or how public comments would be handled.
  • The current State Finance Law text was not supplied, so what purchasing rules already apply and how this proposal would interact with them could not be verified.

Case for#

  • The bill appears intended to support in-state PPE production and supply capacity by directing covered public and publicly funded health care purchases toward New York-made products.
  • A possible argument for the rule is that public purchasing could create demand for local products, while the availability and specification conditions avoid requiring purchases of products that cannot meet the stated needs.
  • The waiver grounds provide an exception when no New York supply exists or when the price difference exceeds 20%, and public posting gives the public a chance to comment.

Case against#

  • The rule could require covered entities to pay more for New York-made PPE when it costs up to 20% more than comparable out-of-state PPE, because that price difference alone would not meet the stated waiver test.
  • The bill does not explain how “required specifications” would be set or who would decide whether a product meets them.
  • The commissioner’s identity and waiver process are unclear, which could make it harder to predict how consistently the rule would be applied.